Publication & Date:Brain Stimulation(2018) Investigators:SZibman, E Daniel, U Alyagon, A Etkin, A ZangenRead More
This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. BrainsWay D treatment is FDA cleared for patients with MDD who failed to respond to one or more anti-depressants in the current episode.
Neuroimaging studies suggest that the medial prefrontal cortex (mPFC) plays a central role in cognitive theory of mind (ToM).
To assess more definitively, using deeptranscranial magnetic stimulation (dTMS), whether the mPFC plays a central role in ToM.
Sixteen healthy participants (10 females, 6 males) completed tasks assessing cognitive and affective ToM following low-frequency dTMS to bilateral mPFC in active-stimulation and placebo-stimulation sessions.
There was no effect of dTMS on either cognitive or affective ToM performance. When examining self-reported empathy, however, there was evidence for a double dissociation: dTMS disrupted affective ToM performance for those with high self-reported empathy, but improved affective ToM performance for those with low self-reported empathy.
mPFC appears to play a role in affective ToM processing, but this study suggeststhat stimulation outcomes are dependent on baseline empathic abilities.